Evidence map›Paper›PMID 36119042›Full record

ArticleFrontiers in immunology2022

Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia.

Regina Michelis, Lama Milhem, Evleen Galouk, Galia Stemer, Ariel Aviv, Tamar Tadmor, Mona Shehadeh, Lev Shvidel, Masad Barhoum, Andrei Braester

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Regina MichelisThe Institute for Medical Research, Galilee Medical Center, Nahariya, Israel.
Lama MilhemThe Institute for Medical Research, Galilee Medical Center, Nahariya, Israel.
Evleen GaloukThe Institute for Medical Research, Galilee Medical Center, Nahariya, Israel.
Galia StemerAzrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Ariel AvivDepartment of Hematology, Emek Medical Center, Afula, Israel.
Tamar TadmorHematology Unit, Bnai Zion Medical Center, Haifa, Israel.
Mona ShehadehBiochemistry Laboratory, Galilee Medical Center, Nahariya, Israel.
Lev ShvidelHematology Institute, Kaplan Medical Center, Rehovot, Israel.
Masad BarhoumAzrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Andrei BraesterAzrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Bar-Ilan University · ILWestern Galilee Hospital · ILBnai Zion Medical Center · ILEmek Medical Center · ILHebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic lymphocytic leukemia (CLL), the most common adult's leukemia in the western world, is caused in 95% of the cases by uncontrolled proliferation of monoclonal B-lymphocytes. The complement system in CLL is chronically activated at a low level

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellPregnancy-Associated alpha 2-MacroglobulinsAdultB-LymphocytesFemaleHumansImmunoglobulin GLymphocyte CountPregnancyTranscription FactorsImmunoglobulin GPregnancy-Associated alpha 2-MacroglobulinsTranscription Factorsalpha-2-macroglobulin (A2M)B-lymphocyteschronic lymphocytic leukemiaclassical pathway of complementcomplement system

Identifiers

PMID36119042
PMCPMC9478581
OpenAlexW4294193213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.